Overview
- The LP.8.1 variant, part of the Omicron JN.1 lineage, is driving increases in Covid-19 cases across Asia, Europe, and Italy.
- EMA's Emergency Task Force has advised that upcoming Covid vaccines be updated to target the LP.8.1 variant to better protect high-risk populations.
- WHO continues to classify the additional global public health risk of LP.8.1 as low, with symptoms reported to be no more severe than other strains.
- US health authorities have restricted seasonal Covid vaccine approvals to individuals over 65 and those at high risk, reflecting a targeted vaccination strategy.
- Experts anticipate LP.8.1 or its descendants will remain a dominant strain into the upcoming winter, underscoring the importance of updated vaccines for vulnerable groups.